DPIIT recognised startup Government of India
Startup India
Aspire Pharmaceuticals Private Limited
Aspire Pharmaceuticals Private Limited - pharma in Raipur, Chhattisgarh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.53 Lakh
▲ 724% YoY
Net profit · FY 2025
₹1.69 Lakh
Net margin 66.9%
EBITDA · FY 2025
₹1.69 Lakh
EBITDA margin 66.9%
Authorised capital
₹11.7 Cr
Registered with MCA
Paid-up capital
₹11.7 Cr
Issued & subscribed
Open charges
₹21.72 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
4
As per MCA filings
About Aspire Pharmaceuticals Private Limited
Data last updated:
Aspire Pharmaceuticals Private Limited is a private limited company based in Raipur, Chhattisgarh, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chhattisgarh, under CIN U24110CT2020PTC010922. Its GSTIN is 22AAUCA3787H1ZA (Chattisgarh).
The company has an authorised share capital of ₹11.7 Cr and a paid-up capital of ₹11.7 Cr. It is led by directors including Rishabh Chopda and Ashish Chopda.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.11 Kedia Business Park Tatibandh, Raipur, Chhattisgarh, India – 492001.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.53 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.69 Lakh (net margin 66.9%) and EBITDA of ₹1.69 Lakh (EBITDA margin 66.9%).
As per MCA filings, the company has open charges of ₹21.72 Cr on record.
Aspire Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-CG-14-0009633). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24110CT2020PTC010922
Registration Number 010922
Incorporation Date 12 November 2020
ROC Chhattisgarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-CG-14-0009633
Recognitions & Rankings of Aspire Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-CG-14-0009633
Contact details
Aspire Pharmaceuticals Private Limited's registered office is in Raipur, Chhattisgarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No.11 Kedia Business Park Tatibandh, Raipur, Chhattisgarh, India – 492001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aspire Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Aspire Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Aspire Pharmaceuticals Private Limited
FY 2025 filings availableAspire Pharmaceuticals Private Limited reported revenue of ₹2.53 Lakh (up 724% YoY) for FY 2025.
Revenue · FY 2025
₹2.53 Lakh ▲ 724%
Net profit · FY 2025
₹1.69 Lakh margin 66.9%
EBITDA · FY 2025
₹1.69 Lakh margin 66.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 724%
EBITDA CAGR growth
3 years · compounded
▲ 106%
Revenue rose 724% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.69 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.69 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 66.9% | ||||
| Net Profit Margin | 66.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aspire Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aspire Pharmaceuticals Private Limited
Aspire Pharmaceuticals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rishabh Chopda | Director | 12 Nov 2020 | 5 Years 11 Months | Current |
| Ashish Chopda | Director | 12 Nov 2020 | 5 Years 11 Months | Current |
| Navin Deshlahra Also directs: Safe-W Pharma LLP | Director | 01 Mar 2023 | 3 Years 7 Months | Current |
| Usha Sharma | Director | 01 Mar 2023 | 3 Years 7 Months | Current |
Peer comparison
Aspire Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Diamond Sante Therapeutics Private Limited | ₹2.55 Lakh (FY 2020) | -93.0% | Palakkad Dt, Kerala, India | |||
| Acclimate Pharmaceuticals Private Limited | ₹2.55 Lakh (FY 2025) | Pune, Maharashtra, India | ||||
| Rajahmundry Pharmaceuticals Private Limited | ₹2.55 Lakh (FY 2024) | -98.0% | Rajahmundry, Andhra Pradesh, India | |||
| Hands Bio-Tech Private Limited | ₹2.54 Lakh (FY 2024) | 150.0% | Kolkata, West Bengal, India | |||
| Macarty Pharmaceuticals Private Limited | ₹2.54 Lakh (FY 2024) | -46.0% | Lucknow, Uttar Pradesh, India | |||
| Aspire Pharmaceuticals Private Limitedthis company | ₹2.53 Lakh (FY 2025) | ₹1.69 Lakh | 66.9% | 724.0% | Raipur, Chhattisgarh, India | |
| Lotuslife Pharmaceuticals Private Limited | ₹2.53 Lakh (FY 2025) | 16.0% | Delhi, India | |||
| Special Life Pharmaceuticals Private Limited | ₹2.53 Lakh (FY 2024) | -15.0% | Motihari, Bihar, India | |||
| Celestys Pharmaceuticals Private Limited | ₹2.52 Lakh (FY 2018) | 10.0% | Ahmedabad, Gujarat, India | |||
| Space Pharmaceuticals Private Limited | ₹2.51 Lakh (FY 2024) | -29.0% | New Delhi, Delhi, India | |||
| Argen Pharmaceuticals Private Limited | ₹2.51 Lakh (FY 2025) | -91.0% | Delhi, India |
To see the full peer comparison of Aspire Pharmaceuticals Private Limited, buy the company report.
Auditor
Aspire Pharmaceuticals Private Limited is audited by GSG & ASSOCIATES LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GSG & ASSOCIATES LLP | FY 2023 | C400015 |
Shareholding
The shareholding of Aspire Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Aspire Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹21.72 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jan 2025 | 101040740 | Sidbi | ₹1.72 Cr | Open | |
| 22 Dec 2023 | 100835264 | Sidbi | ₹20 Cr | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Aspire Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aspire Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Aspire Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
Active EPFO establishments
1
GST
Aspire Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 22AAUCA3787H1ZA | Chattisgarh | Active | 04 Jun 2021 |
To see the full GST registrations and return filing status of Aspire Pharmaceuticals Private Limited, buy the company report.
Recent activity
Aspire Pharmaceuticals Private Limited has 10 board changes on record since 2020: 7 appointments and 3 cessations. The latest: Navin Deshlahra was appointed as Director on 01 Mar 2023.
AGM
Aspire Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aspire Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chhattisgarh.
Charges
A charge with Sidbi amounted to Rs. 1.72 Cr with Charge ID 101040740 was registered on 30 Jan 2025.
Charges
A charge with Sidbi amounted to Rs. 20.00 Cr with Charge ID 100835264 was registered on 22 Dec 2023.
Appointed
Navin Deshlahra was appointed as Director.
Appointed
Usha Sharma was appointed as Director.
Ceased
Abhishek Sharma ceased to be Director.
Ceased
Anil Deshlahara ceased to be Director.
Ceased
Raunak Deshlahara ceased to be Director.
Appointed
Anil Deshlahara was appointed as Director.
Appointed
Abhishek Sharma was appointed as Director.
Appointed
Ashish Chopda was appointed as Director.
3 earlier events are in the company report.
Frequently asked questions
Aspire Pharmaceuticals is an active private limited company based in Raipur, Chhattisgarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 November 2020 (6+ years old) and is registered under CIN U24110CT2020PTC010922.
Aspire Pharmaceuticals has 4 current directors:
- Rishabh Chopda - Director
- Ashish Chopda - Director
- Navin Deshlahra - Director
- Usha Sharma - Director
The latest financial statements of Aspire Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Aspire Pharmaceuticals is 22AAUCA3787H1ZA, registered in Chattisgarh.
The CIN (Corporate Identification Number) of Aspire Pharmaceuticals is U24110CT2020PTC010922. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aspire Pharmaceuticals was incorporated on 12 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chhattisgarh.
The peers of Aspire Pharmaceuticals by revenue are Diamond Sante Therapeutics Private Limited, Acclimate Pharmaceuticals Private Limited, Rajahmundry Pharmaceuticals Private Limited, Hands Bio-Tech Private Limited, Macarty Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Navin Deshlahra was appointed as Director on 01 Mar 2023. Usha Sharma was appointed as Director on 01 Mar 2023. Abhishek Sharma ceased to be Director on 05 Aug 2022. Aspire Pharmaceuticals has 10 board changes on record in total.
Yes, Aspire Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Aspire Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-CG-14-0009633).
The registered office of Aspire Pharmaceuticals is at Plot No.11 Kedia Business Park Tatibandh, Raipur, Chhattisgarh, India – 492001.